MEK Inhibitors: A Therapeutic Approach to Targeting the Ras-MAP Kinase Pathway in Tumors

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|16|1907-1914

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.16, 2004-06, pp. : 1907-1914

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Notch pathway: A potential therapeutic approach for desmoid tumors

By  

Cancer, Vol. 121, Iss. 22, 2015-11 ,pp. : 4088-4096

Blackwell Publishing

Access to resources Recommend Favorite

RAS/RAF/MEK Inhibitors in Oncology

By  

Current Medicinal Chemistry, Vol. 19, Iss. 8, 2012-03 ,pp. : 1164-1176

Bentham Science Publishers

Access to resources Recommend Favorite

p38 MAP Kinase Inhibitors as Potential Therapeutic Drugs for Neural Diseases

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 11, Iss. 1, 2011-03 ,pp. : 45-59

Bentham Science Publishers

Access to resources Recommend Favorite

Agents Targeting Ras Signaling Pathway

By  

Current Pharmaceutical Design, Vol. 8, Iss. 25, 2002-11 ,pp. : 2259-2267

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies for Overcoming Inherent and Acquired Resistance to EGFR Inhibitors by Targeting Downstream Effectors in the RAS/PI3K Pathway

By  

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 824-833

Bentham Science Publishers

Access to resources Recommend Favorite